1). Grubman MJ, Baxt B. Foot-and-mouth disease.
Clin Microbiol Rev. 2004; 17:465–93.
Article
2). Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus.
Virus Res. 2003; 91:65–80.
Article
3). Baxt B, Becker Y. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells.
Virus Genes. 1990; 4:73–83.
Article
4). Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
J Gen Virol. 1989; 70:625–37.
Article
5). Berinstein A, Roivainen M, Hovi T, Mason PW, Baxt B. Antibodies to the vitronectin receptor (integrin α vβ3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol. 1995; 69:2664–6.
6). Amadori M, Volpe G, Defilippi P, Berneri C. Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine.
Biologicals. 1997; 25:65–73.
Article
7). Johns HL, Berryman S, Monaghan P, Belsham GJ, Jackson T. A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry.
J Virol. 2009; 83:6247–56.
Article
8). Koyama T, Hughes RC. Functional integrins from normal and glycosylation-deficient baby hamster kidney cells. Terminal processing of asparagine-linked oligosaccharides is not correlated with fibronectin-binding activity.
J Biol Chem. 1992; 267:25939–44.
Article
9). Duque H, Baxt B. Foot-and-mouth disease virus receptors: comparison of bovine α v integrin utilization by type A and O viruses. J Virol. 2003; 77:2500–11.
10). Duque H, LaRocco M, Golde WT, Baxt B. Interactions of foot-and-mouth disease virus with soluble bovine α vβ3 and α vβ6 integrins. J Virol. 2004; 78:9773–81.
11). LaRocco M, Krug PW, Kramer E, Ahmed Z, Pacheco JM, Duque H, et al. A continuous bovine kidney cell line constitutively expressing bovine α vβ6 integrin has increased susceptibility to foot-and-mouth disease virus. J Clin Microbiol. 2013; 51:1714–20.
12). LaRocco M, Krug PW, Kramer E, Ahmed Z, Pacheco JM, Duque H, et al. Correction for LaRocco et al., A continuous bovine kidney cell line constitutively expressing bovine α vβ6 integrin has increased susceptibility to foot-and-mouth disease virus. J Clin Microbiol. 2015; 53:755.
13). Lee SY, Lee YJ, Kim RH, Park JN, Park ME, Ko MK, et al. Rapid engineering of foot-and-mouth disease vaccine and challenge viruses.
J Virol. 2017; 91:e00155–17.
Article
14). Reed LI, Muench H. A simple method of estimating fifty percent end points. Am J lEpidemiol. 1938; 27:493–7.
15). Kim SM, Lee KN, Lee SJ, Ko YJ, Lee HS, Kweon CH, et al. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus.
Antiviral Res. 2010; 87:307–17.
Article
16). Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion.
Cell. 1992; 69:11–25.
Article
17). O'Donnell V, Pacheco JM, Gregg D, Baxt B. Analysis of foot-and-mouth disease virus integrin receptor expression in tissues from naï ve and infected cattle. J Comp Pathol. 2009; 141:98–112.
18). Jackson T, Sheppard D, Denyer M, Blakemore W, King AM. The epithelial integrin αvβ6 is a receptor for foot-and-mouth disease virus.
J Virol. 2000; 74:4949–56.
Article
19). Wang Y, Mao Q, Chang H, Wu Y, Pan S, Li Y, et al. Inability of FMDV replication in equine kidney epithelial cells is independent of integrin αvβ3 and αvβ6.
Virology. 2016; 492:251–8.
Article
20). Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T. Specificity of the VP1 GH loop of foot-and-mouth disease virus for αv integrins.
J Virol. 2006; 80:9798–810.
Article
21). Neff S, Mason PW, Baxt B. High-efficiency utilization of the bovine integrin α vβ3 as a receptor for foot-and-mouth disease virus is dependent on the bovine β3 subunit. J Virol. 2000; 74:7298–306.
22). Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
J Virol. 2000; 74:1641–7.
Article